In a systematic search for brain-specific proteins, Moore & McGregor (1969 , using a combination of DEAE-cellulose chromatography and starch-gel electrophoresis, were able to detect two highly acidic proteins, apparently occurring exclusively in nervous tissue. These were designated 14-3-2 and S-100 (Moore, 1965 (Moore, , 1973 Moore & Perez, 1968) . Protein 14-3-2, which co-purifies with protein S-100 until the later stages of preparation, was, in the decade after its discovery, intensively studied simply as a tissue-specific protein of unknown function, sensitive immunological methods being used in its determination (Moore & Perez, 1968; Moore, 1973) . It was found to be a protein with minimum mol.wt. 40000-50000, showing a strong tendency to aggregate and having, like protein S-100, a high content of glutamic and aspartic residues (Grass0 et al., 1977) . Detailed studies of tissue distribution confirmed that it was essentially confined to the nervous system, but that, in contrast with protein S-100, protein 14-3-2 was apparently specific to neurons (Cicero et al., 1970~) . Dramatic increases in both proteins were detected during development, and these were correlated with the functional maturation of the nervous system (Cicero et al., 1970b) .
Ten years after its discovery, protein 14-3-2 was shown by Bock & Dissing (1975) to have enolase activity, and this finding brought together studies on this brain-specific protein and work on enolase isoenzymes that had been proceeding independently.
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Enolase is a glycolytic enzyme with a virtually universal distribution in Nature. It is a dimer with subunits of mol.wt. about 4000CL-45 OOO and is known to occur as isoenzymes not only in animals but also in yeasts. The existence of two types of subunit, a and P, in vertebrates is sufficient to explain the enolase isoenzymes of most tissues. Thus liver contains predominantly the homodimer aaenolase and the mature skeletal muscle has only PP-isoenzyme (Rider & Taylor, 1974 . These isoenzymes can be separated electrophoretically or by chromatography, and the purified homodimers can be induced to form hybrids in uitro. Specific antisera were prepared against the two subunit types, and these together caused virtually complete inhibition of enolase activity in all tissues tested except brain. In this tissue approx. 30% of the activity was resistant to these antisera (Rider 19 Taylor, 19756) .
Subsequently it was shown by several groups that brain extracts could be separated to give three distinct isoenzymes of enolase, two of which contained a previously unknown acidic subunit of enolase, designated y (Pearce et al., 1976; Fletcher et al., 1976; Chen & Giblett, 1976) .
The essential features of the set of brain enolase isoenzymes are given in Fig. 1 , which shows their gradient elution from a DEAE-Sephadex column. The first peak is acr-enolase, the last is y y-enolase and the intermediate is the hybrid a y-isoenzyme. This conclusion is supported not only by the electrophoretic properties of the enolase in these peaks but also by immunological analysis performed with the antiserum against cr-enolase and another raised against the supposed y-enolase of the third peak. Peak 1 is susceptible only to anti-(a-enolase) serum, peak Embryo age (days)
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Age after birth (days) Fig. 2 . Changes in the susceptibility of brain enolase activity to anti-( a-enolase) and anti-(y-enolase) sera during development of the mouse 0 , Percentage activity susceptible to treatment with anti-(a-enolase) serum; A, percentage activity susceptible to anti-(y-enolase) serum; 0, total enolase activity.
3 only to anti-(y-enolase) serum, whereas the activity of the intermediate peak is inhibited by both.
Identity between the protein 14-3-2 and yy-enolase, which seems inescapable in view of the similar electrophoretic properties and methods of preparation, was confirmed by Bock et al. (1978) . Firstly, in enolase-inhibition studies, to antiserum raised against protein 14-3-2 inhibited aa-, a y -and yyenolases to precisely the same extent as did the antiserum raised against y-enolase. Secondly, in crossed immunoelectrophoresis both a y -and yy-enolase peaks were shown to react with anti-(protein 14-3-2) serum. Since Moore (1965) originally postulated protein 14-3-2 as the monomer, it is probably best to regard that protein as identical with the y-subunit rather than with the enzymically active dimer. Acceptance of this view allows an explanation of two separable forms of protein 14-3-2 reported by Bock & Dissing (1975) and Roda ef al. (1977) .
In developmental studies of the brain it is important to consider changes in all three brain enolases together, and this can be done either directly by assaying the size of the activity peaks arising in gradient-elution chromatography (Fletcher et al., 1976) , or indirectly by determining the susceptibility of the enolase activity to different subunit-specific antisera (Fletcher et al., 1978) . Thus, as shown in Fig. 2 , although enolase is readily detected in early foetal brain of the mouse, there was no reaction with anti-(y-enolase) serum, all activity apparently being due to aa-enolase. From 16 days of gestation y-enolase is present, and this increases in activity until in the mature brain more than 50% inhibition is obtained with anti-(y-enolase) serum. Parallel studies on development of rat brain showed that early foetal brain contained only aa-enolase isoenzyme, but that from late in foetal life a y-and yy-enolases appeared in increasing amounts until all three isoenzymes occurred in approximately equal activities in the adult. The proportions of nu-, ay-and yy-enolases were calculated as 79 : 2 1 :O in late foetal brain and 37 : 34 : 30 in the mature organ.
The tissue distribution of 'brain enolase isoenzymes' has been studied by immunospecific enzyme inhibition (Fletcher et al., 1978) , by radioimmunoassay (Schmechel et al., 1978) and recently by a very effective combination of ion-exchange chromatography and radioimmunoassay (Hullin et al., 1980) . These more sensitive methods demonstrate finite amounts of ayand yy-enolases in many non-neuronal tissues but in quantities much smaller than found in brain. Immunocytochemical localization has been camed out, mainly by the peroxidase method, by using antisera specific for particular isoenzymes of enolase or for protein 14-3-2 (Pickel et aL, 1976; Persson er al., 1978). These studies conform the predominantly neuronal location of yy-enolase and suggest its association with nuclear membrane and endoplasmic reticulum. Particularly noteworthy is the finding that the cells of the amine precursor uptake and decarboxylation (APUD) system apparently contain y-reacting enolase protein (Schmechel et al., 1978) .
The original question of the function of the brain-specific protein 14-3-2 is only partially answered by the finding that it is a particular subunit of enolase. A second and more intriguing question arises, namely why should there be a special enolase isoenzyme for neuronal cells? For many isoenzyme sets, differences in the kinetic and other properties of the individual isoenzymes may readily be interpreted in relation to metabolic regulation and are sufficient to explain the selective advantage that the existence of the multiple forms confers on the organism.
However, this is not the case for enolase. In the first place it is not clear how differences in kinetic parameters of the enolase isoenzymes could markedly influence metabolism, since enolase is generally regarded as an 'equilibrium enzyme' (Newsholme & Start, 1973) and no regulatory features are known for it. Moreover, studies on the kinetic properties (Rider & Taylor 1974 , 1975a Fletcher, 1977) show only slight differences between the isoenzymes, although some differences in the relative stabilities of the several forms were noted . It is perhaps in the highly acidic nature of the brain enolase that its function should be sought, and it is noteworthy that the brain-specific form of aldolase is also the most acidic of its isoenzyme set. Ureta (1978), in attempting to explain the existence of several isoenzyme sets for which no kinetic differences are known, has stressed the possibility that the association of 'soluble' enzymes, either with each other or with structural components of the cell, is more common than currently appreciated. If such associations are isoenzymespecific, they might provide the basis of the selective advantage that presumably accrues to organism in the specifically neuronal location of the yy-enolase. , 1979) . This specific localization of myelin basic protein on the oligodendrocyte-myelin-sheath compartment has revealed that some processes from oligodendrocytes are over 30pm long (Sternberger et al., 1978) .
Myelin in the central nervous system contains two major protein components, the proteolipid protein and the myelin basic protein, which together account for about 80-85% of the total protein of the membrane system (Rumsby & Crang, 1977;  Boggs & Moscarello, 1978a; Rumsby, 1978) . Of these two main protein species myelin basic protein accounts for about 30% of the total protein of myelin. The ratio of myelin basic protein to proteolipid protein varies depending on the region of the central nervous system (Carnegie & Dunkley, 1975) . Central nerve tissue is rich in myelin basic protein because myelin represents a major part of the white matter. There is some 9 g of myelin basic protein in a human brain. The protein can be easily recovered from central nervous tissue and purified by chromatographic procedures (Deibler et al., 1972; Banik & Davison, 1973) . However, myelin basic protein is rather unstable and is readily degraded into polypeptide fragments of lower molecular weight during isolation, during purification and on storage.
Several methods of assay give molecular weights for myelin basic protein in bovine and human central nerve tissue of 18 300 and 18500 respectively (Carnegie & Dunkley, 1975) . The bovine protein contains 169 amino acid residues, and its extremely basic nature is due to the presence of 18 arginine, 13 lysine and 10 histidine residues. The isoelectric point of the protein is above pH 10.6. The complete amino acid sequence of myelin basic protein from bovine, rat and human species has been elucidated (Carnegie, 1971; Brostoff et al., 1974; Dunkley & Carnegie, 1974) . Points of interest are a proline-rich sequence at residues 96-101, an absence of thiol groups and the fact that the basic amino acid residues are spaced throughout the polypeptide chain, leaving some short sections of amino acids that lack charged residues and that may be more hydrophobic in character. The N-terminus is acetylated, and arginine-107 may occur in free, monomethylated or dimethylated forms (Braun & Brostoff, 1977) . Additionally, the protein can be isolated in a phosphorylated condition. Protein kinases in myelin and nerve tissue can phosphorylate specific serine and threonine sites in the myelin basic protein molecule (Braun & Brostoff, 1977; Carnegie et al., 1974) . Such sites can be dephosphorylated by the action of phosphoprotein phosphatases (Carnegie & Dunkley, 1975) . In myelin basic protein isolated from guinea-pig brain tissue some 50% of the purified protein is unphosphorylated (Deibler et al., 1975) ; the remaining protein molecules are in various states of modification. Generally, not more than 2mol of phosphate/mol of protein has been detected. The effect of this micro-heterogeneity in myelin basic protein structure on the biological role of the protein is not at all clear. Phosphorylation will alter the net charge on the protein molecule, but will not fully counteract the overall strongly basic nature of the protein.
Methylation of the arginine at residue 107 may be important in determining the conformation of the polypeptide around this region of the molecule (Braun & Brostoff, 1977) .
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